Table 4.
Published studies of the surgical treatment for cholangiocarcinoma recurrence.
| Author | Year | N | Type of Cholangiocarcinoma | Median survival after surgical treatment (months) | 3- year survival after surgical treatment (%) | 5- year survival after surgical treatment (%) |
|---|---|---|---|---|---|---|
| Yamamoto (14) | 2001 | 4 | ICC | 10 | 29 | 29 |
| Ohtsuka (15) | 2009 | 9 | ICC | 22 | 51.4 | 51.4 |
| Kamphues (17) | 2010 | 9 | ICC | 51 | 52 | 34.4 |
| Ercolani (16)* | 2010 | 6 | ICC | 66.6 | 60 | 0 |
| Saiura (18) | 2011 | 5 | ICC | Not available | 80 | 60 |
| Sulpice (19) | 2012 | 4 | ICC | Not available | 100 | 75 |
| Spolverato (20) | 2016 | 41 | ICC | 26.1 | Not available | Not available |
| Si (21) | 2017 | 72 | ICC | 25.6 | 53 | 35.3 |
| Bartsch (22) | 2019 | 17 | ICC | 65.2 | 85 | 62 |
| Song (9) | 2011 | 27 | ICC + HiCC + DCC | 18.9 | Not available | Not available |
| Takahashi (10) | 2015 | 74 | Biliary tract** | Not available | 37 | 14 |
| Noji (11) | 2015 | 27 | Biliary tract excluding ICC | Not available | 31 | 23 |
| Miyazaki (12) | 2017 | 14 | Biliary tract** | 28.5 | 38 | 19 |
| Sakata (23) | 2021 | 52 | Biliary tract** | 33 | 50 | 29 |
| Current Study | 2021 | 18 | ICC + HiCC + DCC | 15 | 16.6 | 0 |
* Includes all treated patients (surgery or radiofrequency ablation).
** Biliary tract includes Gall bladder.
ICC, Intrahepatic cholangiocarcinoma; HiCC, Hiliar cholangiocarcinoma; DCC, Distal cholangiocarcinoma.